Treatment Of Peripheral Neuropathy In Diabetic Patient

AN OPEN LABELLED RCT STUDY ON ASSESSMENT OF COMBINED EFFICACY OF SIRAVYADHA, MADHUTAILIKA BASTI, VATARI RASA AND SHILAJATU RASAYANA IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY (MADHUMEHA UPADRAVA) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058085

Enrollment

Registered

2023-09-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G64- Other disorders of peripheral nervous system Health Condition 2: G63- Polyneuropathy in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Male and Female Subjects Of Age Between 25 To 70 Years History Of Diabetes Within 10 Years Diagnosed Cases Of Diabetic Periphearal Neuropathy Who Are Ready To Sign Informed Consent Form Patients Who Are Fit For Basti Siravyadha

Exclusion criteria

Exclusion criteria: Neuropathy Due To Other Causes Except Diabetes Patients Having Diabetes Mellitus 1 Patients Having Diabetic Complication Other Than Neuropathy Radiculopathies Also The Subjects Suffering From Severe Systemic Disorders Which Interferes With Course Of Intervention Will Be Excluded

Design outcomes

Primary

Measure	Time frame
Relief From Subjective Parameters Daha, Shula, Chimicgimayana, Supti, Dourbalya( Diabetes Peripheral Neuropathy Symptoms)Timepoint: 8 Weeks 3 Days	—

Secondary

Measure	Time frame
Nerve conduction Study ChangesTimepoint: 8 Weeks 3 Days	—

Countries

India

Contacts

Public ContactDr PALLAVI

Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary

drfareedabegumshaikh@gmail.com9886478611

Outcome results